Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and ...

Discover effective strategies to minimize sickle cell pain crises and avoid hospitalizations. Leading hematologists share ...

MOROGORO: The provision of screening services for sickle cell Disease and diabetes type one in newborns has continued to be ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

Esther Nkemakolam runs her fingers through kinetic sand and sings a “Moana” song as UPMC Children’s Hospital nurse Taylor ...

Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...